Retinoic acid (RA), the active derivative of vitamin A, has been implicated in various steps of cardiovascular development. The retinaldehyde dehydrogenase 2 (RALDH2) enzyme catalyzes the second oxidative step in RA biosynthesis and its loss of function creates a severe embryonic RA deficiency. Raldh2 ؊/؊ knockout embryos fail to undergo heart looping and have impaired atrial and sinus venosus development. To understand the mechanism(s) producing these changes, we examined the contribution of the second heart field (SHF) to pharyngeal mesoderm, atria, and outflow tract in Raldh2 ؊/؊ embryos. RA deficiency alters SHF gene expression in two ways. First, Raldh2 ؊/؊ embryos exhibited a posterior expansion of anterior markers of the SHF, including Tbx1, Fgf8, and the Mlc1v-nlacZ-24/Fgf10 reporter transgene as well as of Islet1. This occurred at early somite stages, when cardiac defects became irreversible in an avian vitamin A-deficiency model, indicating that endogenous RA is required to restrict the SHF posteriorly. Explant studies showed that this expanded progenitor population cannot differentiate properly. Second, RA up-regulated cardiac Bmp expression levels at the looping stage. The contribution of the SHF to both inflow and outflow poles was perturbed under RA deficiency, creating a disorganization of the heart tube. We also investigated genetic cross-talk between Nkx2.5 and RA signaling by generating double mutant mice. Strikingly, Nkx2.5 deficiency was able to rescue molecular defects in the posterior region of the Raldh2 ؊/؊ mutant heart, in a gene dosage-dependent manner.
C
ardiogenesis requires specification, proliferation, differentiation, and migration of cell populations from diverse sites. Retinoic acid (RA), the active derivative of vitamin A, by acting as a diffusible activator of nuclear receptors, critically regulates a variety of steps and stages of cardiovascular development (1) . Various animal models have been used to examine RAdependent heart development, including knockout mice deficient in retinaldehyde dehydrogenase 2 (RALDH2), which catalyzes the second oxidative step in RA biosynthesis. Raldh2 Ϫ/Ϫ mutants exhibit a severe deficiency in RA production, defects of heart looping (2, 3), reduced posterior chamber (atria and sinus venosus) outgrowth, and defective ventricular trabeculation (4) .
RA has been implicated in the early specification and patterning of the cardiac field in zebrafish and avian embryos (5, 6) . In the gastrulating chicken embryo, Raldh2 is first expressed by mesodermal cells posterior to Hensen's node, coinciding with a critical period for anterior-posterior specification of cardiac precursor cells (7) . Fate mapping in chicks has shown that Raldh2-expressing cells in the lateral mesoderm reside in the proximity of sinoatrial precursors, allowing the diffusion of RA into the cardiac field. Treatment with RA receptor antagonists alters the cardiac fate map and leads to the abnormal presence of ventricular precursors in the posterior cardiac field (7, 8) .
Further supporting the idea that endogenous RA acts as a regionally restricted signal imparting a sinoatrial fate to cardiac precursor cells, both dietary vitamin A-deficient quail embryos and Raldh2 Ϫ/Ϫ knockout mice display abnormal hearts, with a highly hypoplastic inflow tract region and reduced Tbx5 and Gata4 expression (4, 6) .
Recent findings have changed our view of the origin of cardiac progenitor cells in the mouse embryo. Indeed, several studies have demonstrated that myocytes of the early heart tube derive from two distinct progenitor populations (reviewed in ref. 9) . The heart tube is derived from cells of the first heart field (FHF), which begins differentiation at an early stage and mainly contributes to the left ventricle, and in part to the right ventricle and atria. The second heart field (SHF) is a population of undifferentiated multipotent cardiac precursor cells originating from the pharyngeal mesoderm, which first lie medial to the FHF (9) . When the FHF differentiates as myocardium, the SHF is left in the forming coelomic or pericardial cavity and lies ventral to the foregut. It is from this position that SHF cells proliferate and are progressively added to the poles of the heart tube (10, 11) . The SHF provides the precursor cells of the outflow tract (OFT) and also participates in the formation of the right ventricle and atria (10, 12) . Growing evidence suggests the primary site of action of RA may not be in the FHF but in the SHF. Both the Raldh2 Ϫ/Ϫ mutants rescued from early lethality by RA supplementation (13) and a hypomorphic Raldh2 mutant (14) exhibit abnormalities of the OFT and large vessels, reminiscent of the human DiGeorge syndrome and similar to the phenotypes of murine gene knockouts affecting the SHF, including an Fgf8 hypomorphic and Tbx1-and Foxh1-null mutations (reviewed in refs. 9 and 15). In later-stage RA-deficiency mutants, OFT defects are accompanied by a profound disorganization of the posterior pharyngeal region and reduced endodermal and mesodermal expression of Fgf8, Hoxa1, and Hoxb1 (13, 14) .
Here, we used several approaches to examine the contribution of the SHF to pharyngeal mesoderm, atria, and OFT in RAdeficient mouse embryos. By using the Mlc1v-nlacZ-24 reporter line, in which a lacZ transgene has been inserted upstream of the Fgf10 gene (16), we show that the anterior part of the SHF is disorganized and posteriorly expanded in Raldh2 Ϫ/Ϫ mutants, beginning at the four-to five-somite (forming heart tube) stage. The endogenous patterns of Tbx1 and Fgf8 expression confirm this caudal expansion also seen with Islet-1 (Isl1), which marks the whole SHF. Explant studies indicated that the differentiation of cardiac progenitor cells located in the SHF is compromised under Raldh2 deficiency, likely because of alterations in growth factor signaling. In mutant embryos, the OFT, which derives from the SHF, is absent and there is a severe disorganization of the inflow tract. By using additional lacZ reporter transgenic lines, we show that the RA-deficient heart tube is mainly formed of myocardial cells with a right and left ventricular identity, suggesting that the FHF contribution is not altered. Altogether, these results document a role of RA in regulating SHF dynamics.
In the zebrafish embryo, RA deficiency leads to an enlargement of the early domains of Nkx2.5 expression, suggesting that RA restricts the allocation of cardiac progenitors in the forming cardiac field (5) . Here, we provide evidence that the regulation of Nkx2.5 by RA signaling may be direct, because we found that the upstream regulatory region of the murine Nkx2.5 gene contains five evolutionarily conserved RA-response elements of the direct-repeat 5Ј (DR5) type, which may control late aspects of Nkx2.5 regulation in SHF-derived OFT cells. To further examine Raldh2-Nkx2.5 cross-regulation, we generated double mutant mice and found that Nkx2.5 haploinsufficiency partly rescues the posterior-anterior gradient of Tbx5 expression in the heart tube of Raldh2 Ϫ/Ϫ mutants.
Results
To assess retinoid activity in the WT cardiac field, we used mice harboring the RARE-hsp68-lacZ transgene, a sensitive reporter for endogenous RA activity (17) . This transgene has been shown to be expressed in the posterior region of the early heart (8), and we confirmed that expression was localized to two dorsal-medial streams of the forming heart tube (Fig. 1A, arrowheads) , a domain absent in Raldh2 Ϫ/Ϫ mutants (data not shown). At the five-somite stage, Raldh2 and Tbx5 expression domains converged to overlap in the most posterior cardiac precursors in the splanchnic mesoderm ( Fig. 1 B and C) . Similar domains of the RA-responsive Hoxa1 homeobox gene (18) were present adjacent to the cardiac field in WT embryos at the five-to eightsomite stages (Fig. 1 D, E , and G), but these domains were absent in Raldh2 Ϫ/Ϫ embryos ( Fig. 1 F and H) .
We crossed Raldh2 ϩ/Ϫ mice with the Mlc1v-nlacZ-24 line, in which a transgene integration into the Fgf10 locus leads to transgene expression in the cardiac progenitors located in the anterior heart field and, because of perduration of ␤-galactosidase (␤-gal), activity allows for marking the corresponding myocardial derivatives (16) . Although the early expression of this reporter transgene did not show a major difference between WT and Raldh2 Ϫ/Ϫ mutants at the one-to two-somite stages ( Fig. 2  A and B) , from the five-somite stage, its expression was clearly altered in mutants. First, the labeled cells were dramatically expanded toward posterior regions (compare Fig. 2 C and D,  arrowheads) , an alteration that was accentuated at the sevensomite stage (Fig. 2 E-JЈ) . Thus, in Raldh2 Ϫ/Ϫ mutants the X-gal staining was present in the lateral mesoderm well beyond the level of the developing heart tube (compare Fig. 2 IЈ with JЈ, arrowheads). Second, the closure of the dorsal mesocardium was defective, because the midline gap in X-gal staining became progressively wider in the Raldh2 Ϫ/Ϫ mutants ( Fig. 2 D, F , and J, brackets). To examine the activation of the Mlc1v-nlacZ-24 transgene in the lateral mesoderm lying posterior to the heart tube, explants from this region were dissected at the zero-to two-somite stage (a stage at which the transgene is not activated posteriorly in Raldh2 Ϫ/Ϫ embryos; the WT second and third pharyngeal arches (Fig. 2K , arrowheads) was absent in mutants, although expression was detected in the anterior portion of the ''unlooped'' heart tube ( Fig. 2 
K and L).
We examined expression of other anterior markers of the SHF such as Fgf8 and Tbx1. Fgf8 expression was more intense and caudally expanded in Raldh2 Ϫ/Ϫ mutants, from the three-to four-somite stage onward ( Fig. 3 A-D) . As for the Mlc1v-nlacZ-24 transgene, Fgf8 expression was detected in the posterior lateral mesoderm of the Raldh2 Ϫ/Ϫ mutant embryos at the eight-somite stage ( Fig. 3 CЈ and DЈ; the greater expansion of the Mlc1v-nlacZ-24 transgene may be attributable to ␤-gal stability). The T-box gene Tbx1, frequently deleted in human 22q11 deletion DiGeorge syndrome (reviewed in ref. 15 ), appears to be genetically upstream of Fgf8 (19) (20) (21) (22) . WT embryos exhibited pronounced Tbx1 expression in the SHF region caudal-medial to Mlc1v-nlacZ-24 reporter staining ( Fig. 3 E and EЈ) , whereas Tbx1 expression appeared more intense and expanded in range in Raldh2 Ϫ/Ϫ mutants starting at the three-to four-somite stage ( Fig. 3 F and FЈ and data not shown) . We also examined expression of a pan-SHF progenitor cell marker, Isl1 (10). Isl1-expressing cells in the splanchnic mesoderm give rise to cardiomyocytes of the OFT, the right ventricle, atria, and inflow region of the heart (10). Isl1 is also expressed in ventral and lateral foregut endoderm (see Fig. 3GЈ ). Caudal expansion of Isl1 expression was observed in Raldh2 Ϫ/Ϫ mutants ( Fig. 3 G and  H) , but the labeled cells did not extend into the heart tube where cardiomyocytes are present (Fig. 3 GЈ and HЈ) . Altogether, these observations suggest that endogenous RA may control the antero-posterior location of cardiac progenitors of the SHF within the splanchnic mesoderm.
Excess RA levels can often affect the same RA-regulated signaling pathways as RA deficiency but in an opposite manner. This was found to be the case when a single dose of RA was administered to WT mice at late gastrulation (E7.5). These treatments resulted in marked reductions of endogenous Fgf8 and Isl1 transcripts and of Mlc1v-nlacZ-24 reporter transgene staining [supporting information (SI) Fig. 6 ].
We then examined Raldh2 Ϫ/Ϫ mutants for endogenous expression of Bmp2, -4, -6 and -7, which encode TGF␤ family members influencing myocardial differentiation (reviewed in ref. 23 ). We found Bmp6, Bmp7 (SI Fig. 7 A-D) , and Bmp2 (see Fig. 5 F and H) levels to be reduced in the inflow region of the mutants. Interestingly, at later stages (E9.0), Tgf␤2 expression was markedly increased at the venous pole (septum transversum) of the Raldh2 Ϫ/Ϫ unlooped heart (SI Fig. 7 E and F) . A similar hyperactivation of TGF␤ signaling is observed in foregut tissues of Raldh2 Ϫ/Ϫ mutants at E8.5 and has been implicated in the lack of lung induction (24) .
The reductions in levels of Mlc1v-nlacZ-24 transgene expression (an Fgf10 enhancer trap) in the pharyngeal mesoderm of Raldh2 Ϫ/Ϫ mutants at E9 (Fig. 2 K and L) suggest that FGF signaling may be affected in the SHF. To further investigate this pathway, we performed immunolocalization of p-ERK1/2, effectors of MAP signaling whose phosphorylation correlates with FGF activity in the cardiac region (25) . p-ERK1/2 levels were found to be lower in the SHF at the 10-somite stage in Raldh2 Ϫ/Ϫ embryos (SI Fig. 7 G and H) . Consistent with the decrease of p-ERK levels, the expression of other FGF downstream targets (Sprouty1 and -2 and Mkp3; SI Fig. 7 I-JЈ and data not shown) was also reduced in the pharyngeal region and splanchnic mesoderm of mutants.
To examine myocardial subdomains in the RA-deficient hearts, we crossed Raldh2 ϩ/Ϫ mutants with additional, region-specific reporter transgenes. The y96-Myf5-nlacZ-16 transgene displays a domain of expression in the WT OFT myocardium beginning at the 12-to 14-somite stage (26) , which was absent in Raldh2 Ϫ/Ϫ mutants (Fig. 4 A and B) . The absence or reduction of OFT myocardium in mutants was confirmed by the Mlc3f-nlacZ-9 pattern (Fig. 4 C and  D) . This transgene is known to be silenced in WT OFT myocardium (12) (Fig. 4C, bracket) . In mutants, most if not all of the unlooped heart tube contained Mlc3f-nlacZ-9-labeled cells (Fig. 4D ). These observations indicate that the deployment of SHF cells to the OFT was highly compromised in Raldh2 Ϫ/Ϫ mutant embryos. In contrast, the activity of the Mlc3f-nlacZ-2E transgene, normally expressed in left but not right ventricular myocardium (Fig. 4 E and G) , was well detected in the Raldh2 Ϫ/Ϫ heart tube (compare Fig. 4 E and G with F and H) (12) . These results strongly suggest that FHF contribution is not affected under RA deficiency. To estimate the myocardial cell numbers and the presence of differentiating cardiomyocytes in the Raldh2 Ϫ/Ϫ mutant hearts, we counted the number of ␤-gal-positive and ␣-actinin-positive cells on serial sections of WT and Raldh2 Ϫ/Ϫ embryos from the Mlc3f-nlacZ-9 line (SI Fig. 8 ). At E9.5, we estimated a deficiency of Ϸ30%, both in the overall number of ␤-gal-positive cells and of differentiating (␣-actinin-positive) cardiomyocytes in Raldh2 Ϫ/Ϫ mutants, which may correspond to the defects observed in the outflow and inflow regions.
To further explore the differentiation potential of Raldh2 Ϫ/Ϫ cardiomyocytes, explants of SHF isolated from three-to fivesomite stage WT and Raldh2 Ϫ/Ϫ embryos carrying the Mlc1v-nlacZ-24 transgene were cultured for 48 h and X-gal-stained to identify SHF cells and derivatives (12, 16) . Under these established culture conditions, WT SHF explants consistently underwent cardiac differentiation, characterized by the presence of beating cells and expression of myosin heavy chain (MF20), quite similar to heart explants cultured from the same embryos (SI Table 1 ; also see ref. 12). Raldh2 Ϫ/Ϫ mutant SHF explants, however, never differentiated or formed beating cardiomyocytes, in contrast to their heart, which was still beating under the same culture conditions (SI Table 1 ). This suggested that the Raldh2 Ϫ/Ϫ mutant SHF was impaired in its ability to contribute to differentiated cardiomyocytes, potentially because of reduced bone morphogenetic protein (BMP) signaling.
The intriguing finding that both Raldh2 deficiency and RA receptor antagonism in zebrafish embryos resulted in the production of excess myocardial progenitors, marked by upregulated Nkx2.5 expression during gastrulation (5), led us to investigate potential mechanisms for cross-regulation between the retinoid and Nkx2.5 transcriptional pathways. One avenue to examine such interactions is to generate compound mutants. Insertion of a Cre transgene in the Nkx2.5 locus (27) disrupts expression of this gene, so that when mated to homozygosity, the resulting embryos phenocopy previously reported Nkx2.5 Ϫ/Ϫ mutants (27) (28) (29) . We crossed Nkx2.5-Cre mutants with Raldh2 ϩ/Ϫ mice and analyzed compound mutants at E8.5 for Tbx5 expression as a marker for the posterior portion of the heart, which is destined to become the sinus venosa and atria (30) . As expected, the domain of Tbx5 expression was reduced in Raldh2 Ϫ/Ϫ embryos (compare Fig. 5 A with C), correlating with an abnormal morphogenesis of the inflow region (4). Interestingly, Nkx2.5 haploinsufficiency partially rescued Tbx5 expression in Raldh2 Ϫ/Ϫ embryos (Fig. 5D) . Complete Nkx2.5 deficiency further expanded Tbx5 expression in Raldh2 Ϫ/Ϫ ; Nkx2.5 Ϫ/Ϫ compound mutants (Fig. 5E) . Prall et al. (31) have demonstrated that Nkx2.5 deficiency up-regulates Bmp2 expression, which may result in increased myocardial differentiation. We likewise observed expanded Bmp2 expression in our Nkx2.5 Ϫ/Ϫ mutants (Fig. 5G) . Although Bmp2 levels were reduced in Raldh2 Ϫ/Ϫ mutants (Fig. 5H) , we found that these levels were progressively normalized upon removal of functional Nkx2.5 alleles (Fig. 5 I and J) . Additionally, SHF expression, as assayed by Isl1 expression, appeared essentially unaltered in Raldh2 Ϫ/Ϫ mutants under Nkx2.5 deficiency (data not shown).
By performing a VISTA-based promoter search for transcriptional binding sites in evolutionary conserved regions, we uncovered an upstream regulatory region of the Nkx2.5 gene containing five conserved RA-response elements (RAREs) of the DR5 type. A lacZ transgenic line was generated by using a BAC fragment containing the region located from Ϫ14.8 to Ϫ7.5 kb upstream of the Nkx2.5 transcriptional start site, which included the RAREs. This fragment was sufficient to drive lacZ reporter expression in the FHF (SI Fig. 9 A-C) , similar to endogenous Nkx2.5 expression (28) . Whereas the early domain of endogenous Nkx2.5 (data not shown) and Nkx2.5 transgene expression in the cardiac crescent was not altered in Raldh2 Ϫ/Ϫ mutants (SI Fig. 9 D-F) , endogenous Nkx2.5 was expanded in the SHF of mutants at E8.5 (SI Fig. 9 G and H, arrowheads) . However, transgene expression was reduced in the OFT and the right ventricle of RA-supplemented Raldh2 Ϫ/Ϫ embryos at E10.5 (SI Fig. 9 I and J) . These observations suggest that Nkx2.5 regulation is not RA-dependent in the FHF and at early stages in the SHF, although eventually it is affected when RA levels are decreased at later stages of development.
Discussion
Originally RA was proposed to regulate the anterior-posterior specification of cardiac progenitors within the FHF. Indeed, posterior cells of the early FHF are encircled by Raldh2-expressing cells in the lateral mesoderm. Blocking RA signaling in chick embryos inhibited atrial differentiation and altered the cardiac fate map, so that ventricular progenitors extended outside of their normal domains (7). Keegan et al. (5) further have found that RA deficiency results in an expansion of cardiac progenitors during gastrulation in zebrafish, via a direct fate transformation. Our results, although partly consistent with previous findings, now show that RA regulates SHF organization within the precise time frame in which RA deficiency affects cardiac formation in avian and mammalian models. We also observed an overlap between the region of RA signaling and the caudal limit of SHF marker gene expression, correlating with an anterior domain of Hoxa1 expression in WT embryos, a domain that is absent in Raldh2 mutants. Because restoring Hoxa1 expression in RAdeficient amphioxus embryos can rescue patterning defects (32), we postulate that the lack of Hoxa1 expression in the cardiac field may result in cardiac perturbations found in Raldh2 mutants (4) . We found that the earliest events of cardiac RA deficiency were the caudal expansions of SHF gene expression, occurring at a stage when cardiac defects become irreversible in an avian vitamin A-deficiency model (33) . We propose that these initial molecular alterations in SHF expression are why RA-deficient heart formation cannot be restored after this time. Additional reductions in the right ventricle and absence of OFT because of impaired SHF integration in the forming heart tube probably contributes to abnormal cardiac looping also found in other SHF mutants such as Isl1, Mef2c, and Nkx2.5 (10, 31, 34) .
Some genetic cross-talk exists between Nkx2.5 and RA signaling, because we show here that reducing Nkx2.5 gene dosage can rescue aspects of the Raldh2 Ϫ/Ϫ cardiac phenotype, including Tbx5 expression. Nkx2.5 Ϫ/Ϫ mutants have an apparent expansion of the FHF contribution to the left ventricle (31) . Hence it may have been expected that Nkx2.5 loss of function would have worsened the Raldh2 Ϫ/Ϫ cardiac phenotype. More likely it is the feedback repression that Nkx2.5 normally imposes on Bmp2/ Smad signaling (31) , which when relieved may improve the RA deficiency phenotype. Transplantation of W T foregut endoderm, or exogenous supply of BMP2 and Gata4, can restore heart morphology in vitamin A-deficient quail embryos (35, 36) . Although Bmp2 expression indeed appears up-regulated in Nkx2.5;Raldh2 compound mutants, further genetic strategies are required to clarify the precise manner by which these two signaling pathways interact.
The importance of Fgf8 in SHF signaling has been noted (19, 20, 22, 37, 38) . Our study indicates that a primary mechanism by which RA regulates SHF dynamics may be by modulating FGF signaling. We show that endogenous RA is required to prevent Fgf expression in the posterior lateral mesoderm (including in the posterior region of the SHF). Not only did RA deficiency lead to expanded Fgf8 and Fgf10 (Mlc1v-nlacZ-24-enhancer trap) expression, this expansion occurred at approximately the five-somite stage, when cardiac defects become irreversible in the quail vitamin A-deficiency model (33) . Conversely, we saw that excess exogenous RA reduces SHF Fgf8 levels, similar to what has been observed when endogenous RA is increased by blocking the activity of its metabolizing CYP26 enzymes (39) .
One puzzling finding in Raldh2 mutants was that despite the expansion of the SHF at early stages of development, eventually the contribution of SHF cells to the heart tube was compromised. Explant studies demonstrate that mutant SHF cells are impaired in their ability to differentiate and to form beating cardiomyocytes. Several explanations may account for these findings. Reduction in BMP signaling, found in Raldh2 mutants, may lead to the absence of bona fide cardiac induction. Accordingly, FGFs can only elicit cardiomyogenic effects in regions where BMP signaling is also present (40) . Alternately, the expanded early FGF8 signaling may hinder the capacity of the prospective myocardial SHF cells to develop and correctly function, similar to what is observed at slightly later stages when excess FGF8 resulting from cardiac neural crest ablation disrupts myocardial function (37, 41) . Moreover, altering RA-Fgf8 regulatory interactions may produce adverse consequences. In prostate cancer cells, RA activation of the Fgf8 promoter produces a switch of splice isoforms, so that a less mitotically active isoform (Fgf8a) accumulates (42) . Because both canonical and novel RAresponse elements in the Fgf8 promoter can be activated by unliganded RAR␣ in COS cells (43) , an absence of RA may produce an accumulation of the more proliferative Fgf8b product. Hypothetically, the absence of RAR ligand in Raldh2 Ϫ/Ϫ mutants may favor Fgf8b expression, hindering early SHF progenitor differentiation by its increased mitotic activity.
In conclusion, mutual inhibition between FGF and RA pathways may control cardiac stem cell dynamics and cardiomyocyte differentiation, similar to what has been described during caudal neuronal stem cell production and neural tube differentiation (reviewed in ref. 44) . In this tail bud of chick embryos at early somite stages, Fgf8 expression marks the caudal source of neuronal stem cells, which under RA deficiency is expanded. The ability of neural progenitors to differentiate, however, is impaired when RAR signaling is blocked (44) . Similarly we observed that cardiac stem cell populations, marked by Isl1 expression (45), were expanded under RA deficiency, whereas SHF cardiomyocyte differentiation was impaired. Further un- derstanding of how RA regulates cardiac progenitors and growth factor pathways in the early embryo may engender novel ideas about how to regulate cardiac stem cell dynamics in humans.
Materials and Methods
In Situ Hybridization and Immunohistochemistry. Raldh2-null mutant mice have been described (3) as well as the maternal RA supplementation procedure (46) . The lacZ reporter transgenic lines have been described (12, 26) . Wholemount in situ hybridization (ISH) was performed as described (12) by using Intavis InSituPro robots. Double whole-mount ISH with digoxigenin-and FITC-labeled riboprobes were performed according to the Stern laboratory protocol. Transgenic expression was monitored by X-gal assays as described (12) . Whole-mount immunolabeling with anti p-ERK1/2 antibody (Cell Signaling) was performed according to the Rossant laboratory protocol.
Retinoic Acid Treatment of Embryos. All-trans-RA (Sigma) was dissolved in DMSO and diluted at 20 mg/ml. At E7.5, the mice were given a single i.p. injection of the RA solution (65 mg/kg) or control DMSO.
Embryonic Explant Cultures.
The region posterior to the FHF up to the allantois was dissected from zero-to two-somite stage embryos collected and transferred to culture medium in collagen (1%) coated multiwell dishes. For older embryos, the heart tube alone or pharyngeal mesoderm (including pharyngeal endoderm) was dissected and transferred to culture medium. Explants were cultured as described (12) for 36 to 48 h. Fluorescent immunohistochemistry was performed by using the anti-myosin heavy chain antibody MF20
(Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA) at a 1/100 dilution. Explant experiments were repeated several times for each transgenic line and time point (SI Table 1 ).
Analysis of Myocardial Cell Numbers.
Cell counting was assessed on 14-m sections by using rabbit polyclonal anti-␤-Gal (1:500; Cappel) and monoclonal anti-sarcomeric ␣-actinin (clone EA-53, 1:500; Sigma) followed by DAPI staining. The number of myocardial cells (DAPI ϩ nuclei in ␣-actinin ϩ cells) and ␤-gal ϩ cells (combined DAPI ϩ and ␤-Gal ϩ nuclei) were recorded on all serial sections of Mlc3f-nlacZ-9 transgenic embryos (n ϭ 3 for each genotype) at E9.5.
